Please log in to determine if you are eligible to purchase PT Programs.
FLOW CYTOMETRY, PLASMA CELL NEOPLASMS - PCNEO
PCNEO
Analytes/procedures in bold type are regulated for proficiency testing by the Centers for Medicare & Medicaid Services (CMS).
Analyte
Challenges per Shipment
Number of Shipments
Plasma cell neoplasms
3
Two shipments per year
PCNEO is intended to supplement the FL3 program for laboratories performing both technical and interpretive components of leukemia/lymphoma analysis with specialized testing for plasma cells, including intracellular light chain (kappa/lambda) testing.
Participation in this program alone does not satisfy PT requirements for laboratories performing more general analysis of leukemia/lymphoma specimens.
Program Information
One 1.1-mL specimen containing a cell line/whole blood mixture simulating a plasma cell neoplasm with clinical history and pertinent laboratory data
Two online cases consisting of gated dot plots, clinical histories, and pertinent laboratory data
Each challenge includes online images of tissue sections, bone marrow, and/or peripheral blood smears as clinically relevant and/or available.
Online, whole slide images powered by DigitalScope® technology (if applicable)
This program has stability of two days or less. The CAP cannot guarantee performance or offer credits for orders placed for shipment outside of the US and Canada.